Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.
Compare RIGL Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Rigel Pharmaceuticals
The company announced positive results from an important COVID-19 clinical study.
Here's why this stock's big run-up in recent months could be just the beginning.
The company is teaming up with Eli Lilly on the development of a promising immune disease drug.
RIGL earnings call for the period ending September 30, 2020.
RIGL earnings call for the period ending June 30, 2020.
The biotechnology company is hoping to improve coronavirus care.
RIGL earnings call for the period ending March 31, 2020.
Success in clinical trials doesn't guarantee success on the market.
RIGL earnings call for the period ending December 31, 2019.